Artificial Intelligence in Drug Treatment

被引:28
|
作者
Romm, Eden L. [1 ]
Tsigelny, Igor F. [1 ,2 ]
机构
[1] CureMatch Inc, San Diego, CA 92121 USA
[2] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 | 2020年 / 60卷
关键词
artificial intelligence; machine learning; deep learning; personalized medicine; drug combination; combination therapy; BLOOD-BRAIN-BARRIER; FEATURE-SELECTION; PREDICTION; IDENTIFICATION; OPTIMIZATION; POLYPHARMACY; DESCRIPTORS; DATABASE;
D O I
10.1146/annurev-pharmtox-010919-023746
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The most common applications of artificial intelligence (AI) in drug treatment have to do with matching patients to their optimal drug or combination of drugs, predicting drug-target or drug-drug interactions, and optimizing treatment protocols. This review outlines some of the recently developed AI methods aiding the drug treatment and administration process. Selection of the best drug(s) for a patient typically requires the integration of patient data, such as genetics or proteomics, with drug data, like compound chemical descriptors, to score the therapeutic efficacy of drugs. The prediction of drug interactions often relies on similarity metrics, assuming that drugs with similar structures or targets will have comparable behavior or may interfere with each other. Optimizing the dosage schedule for administration of drugs is performed using mathematical models to interpret pharmacokinetic and pharmacodynamic data. The recently developed and powerful models for each of these tasks are addressed, explained, and analyzed here.
引用
收藏
页码:353 / 369
页数:17
相关论文
共 50 条
  • [41] Artificial intelligence in nanotechnology for treatment of diseases
    Heydari, Soroush
    Masoumi, Niloofar
    Esmaeeli, Erfan
    Ayyoubzadeh, Seyed Mohammad
    Ghorbani-Bidkorpeh, Fatemeh
    Ahmadi, Mahnaz
    JOURNAL OF DRUG TARGETING, 2024, 32 (10) : 1247 - 1266
  • [42] Artificial intelligence in drug design
    Feisheng Zhong
    Jing Xing
    Xutong Li
    Xiaohong Liu
    Zunyun Fu
    Zhaoping Xiong
    Dong Lu
    Xiaolong Wu
    Jihui Zhao
    Xiaoqin Tan
    Fei Li
    Xiaomin Luo
    Zhaojun Li
    Kaixian Chen
    Mingyue Zheng
    Hualiang Jiang
    Science China(Life Sciences), 2018, (10) : 1191 - 1204
  • [43] Artificial intelligence in drug design
    Feisheng Zhong
    Jing Xing
    Xutong Li
    Xiaohong Liu
    Zunyun Fu
    Zhaoping Xiong
    Dong Lu
    Xiaolong Wu
    Jihui Zhao
    Xiaoqin Tan
    Fei Li
    Xiaomin Luo
    Zhaojun Li
    Kaixian Chen
    Mingyue Zheng
    Hualiang Jiang
    Science China Life Sciences, 2018, 61 : 1191 - 1204
  • [44] Artificial Intelligence in Drug Toxicity Prediction: Recent Advances, Challenges, and Future Perspectives
    Van Tran, Thi Tuyet
    Wibowo, Agung Surya
    Tayara, Hilal
    Chong, Kil To
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (09) : 2628 - 2643
  • [45] Artificial Intelligence Algorithms for Treatment of Diabetes
    Rashid, Mudassir M.
    Askari, Mohammad Reza
    Chen, Canyu
    Liang, Yueqing
    Shu, Kai
    Cinar, Ali
    ALGORITHMS, 2022, 15 (09)
  • [46] A comprehensive review on recent approaches for cancer drug discovery associated with artificial intelligence
    Pandiyan, Sanjeevi
    Wang, Li
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 150
  • [47] Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
    Karger, Erik
    Kureljusic, Marko
    PHARMACEUTICALS, 2022, 15 (12)
  • [48] Unleashing the future: The revolutionary role of machine learning and artificial intelligence in drug discovery
    Yadav, Manoj Kumar
    Dahiya, Vandana
    Tripathi, Manish Kumar
    Chaturvedi, Navaneet
    Rashmi, Mayank
    Ghosh, Arabinda
    Raj, V. Samuel
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 985
  • [49] Big Data and Artificial Intelligence Modeling for Drug Discovery
    Zhu, Hao
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60, 2020, 60 : 573 - 589
  • [50] Artificial intelligence for dementia drug discovery and trials optimization
    Doherty, Thomas
    Yao, Zhi
    Khleifat, Ahmad A. l.
    Tantiangco, Hanz
    Tamburin, Stefano
    Albertyn, Chris
    Thakur, Lokendra
    Llewellyn, David J.
    Oxtoby, Neil P.
    Lourida, Ilianna
    Ranson, Janice M.
    Duce, James
    ALZHEIMERS & DEMENTIA, 2023, 19 (12) : 5922 - 5933